Personalized genetic testing for children with cancer
Part of Cancer clinical trials.
This trial studies how personalized (tailored) genetic testing can help guide care for children with cancer. It may help match treatment choices to each child’s genetic risk, and it includes optional return of germline (inherited) test results.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (or your child) must be under 18 years old (or aged 19–25 only in special situations, discussed with the study team).
- Your expected lifespan must be more than 6 weeks at the time you join.
- A parent or guardian (if under 18) or the participant (if 18+) must sign informed consent to join the study.
- You must also sign separate consent about germline genetic testing and whether you want those inherited results returned.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests personalized cancer treatments for children and teens whose cancer has not responded to standard therapy. It uses information from precision medicine studies to match the right drug to each child's tumor.
This trial uses a rapid type of genetic testing (whole genome sequencing) to look at the DNA of children and young adults with cancer. The goal is to better understand each person's cancer and potentially guide treatment decisions.
This trial studies the genetic makeup of your tumor to find personalized treatment options, especially if standard treatments have not worked. It aims to match you with experimental treatments that target your cancer's specific changes.
This study looks at how genetic testing can help tailor cancer treatment for children and young adults. It is for patients newly diagnosed with cancer or those preparing for a bone marrow transplant for a non-cancer condition.
This study offers whole-genome testing (a way to read a person’s DNA) to families after a child is newly diagnosed with cancer. It aims to find inherited changes that may explain why cancer happened and guide future care or monitoring.
This study uses gene testing on stored tumor tissue (and a blood sample) to help doctors recommend treatment options that may fit your tumor’s specific changes. It may also help avoid certain medicines and share your de-identified data with other researchers.
Hear when a new Childhood Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.